Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
Research output: Contribution to journal › Article
The objective was to study whether α-synuclein oligomers are altered in the cerebrospinal fluid (CSF) of patients with dementia, including Parkinson disease with dementia (PDD), dementia with Lewy bodies (DLB), and Alzheimer disease (AD), compared with age-matched controls.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Journal||Alzheimer's Research & Therapy|
|Publication status||Published - 2014|
No data available